PTC Inc.: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 4, 2023 and accepted by EDGAR at Aug 4, 2023, 20:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $542.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-10-01 to 2023-06-30 | $1.55bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $115.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-10-01 to 2023-06-30 | $325.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-01 to 2023-06-30 | $426.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-10-01 to 2023-06-30 | $1.23bn | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-01 to 2023-06-30 | $103.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-10-01 to 2023-06-30 | $292.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-01 to 2023-06-30 | $109.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-10-01 to 2023-06-30 | $337.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-04-01 to 2023-06-30 | $35.8m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-10-01 to 2023-06-30 | $93.7m | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-01 to 2023-06-30 | $15.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-10-01 to 2023-06-30 | $44.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | $61.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-10-01 to 2023-06-30 | $199.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-10-01 to 2023-06-30 | $1.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-10-01 to 2023-06-30 | $1.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 119,392,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-10-01 to 2023-06-30 | 119,072,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-10-01 to 2023-06-30 | $561.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-10-01 to 2023-06-30 | $18.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2022-10-01 to 2023-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-06-30 | $281.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $1.10bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $6.21bn | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $1.61bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $3.61bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-06-30 | $1.74bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-06-30 | $2.60bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-038543. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.